Pro Share Advisors LLC Glaukos Corp Transaction History

Pro Share Advisors LLC

$42.5 Billion
Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Glaukos Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 14,869 shares of GKOS stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,869

Previous 10,327 43.98%

Holding current value

$1.54 Million

Previous $1.35 Million 65.72%

% of portfolio

0.01%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$126.42 - $152.67 $574,199 - $693,427	4,542 Added 43.98%	14,869 $2.23 Million
Q3 2024 Nov 13, 2024	BUY	$113.62 - $135.39 $336,883 - $401,431	2,965 Added 40.27%	10,327 $1.35 Million
Q2 2024 Aug 13, 2024	SELL	$89.48 - $118.35 $216,362 - $286,170	-2,418 Reduced 24.72%	7,362 $871,000
Q1 2024 May 08, 2024	BUY	$76.4 - $96.33 $48,666 - $61,362	637 Added 6.97%	9,780 $922,000
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $108,999 - $155,836	1,831 Added 25.04%	9,143 $726,000
Q3 2023 Nov 13, 2023	SELL	$69.23 - $79.09 $13,776 - $15,738	-199 Reduced 2.65%	7,312 $550,000
Q2 2023 Aug 10, 2023	BUY	$45.44 - $71.21 $18,266 - $28,626	402 Added 5.65%	7,511 $534,000
Q1 2023 May 11, 2023	SELL	$43.88 - $52.48 $7,415 - $8,869	-169 Reduced 2.32%	7,109 $356,000
Q4 2022 Feb 02, 2023	BUY	$40.82 - $57.75 $38,329 - $54,227	939 Added 14.81%	7,278 $317,000
Q3 2022 Nov 04, 2022	SELL	$46.84 - $58.49 $7,447 - $9,299	-159 Reduced 2.45%	6,339 $337,000
Q2 2022 Aug 01, 2022	SELL	$34.86 - $63.77 $128,075 - $234,290	-3,674 Reduced 36.12%	6,498 $296,000
Q1 2022 May 10, 2022	SELL	$44.33 - $57.82 $55,102 - $71,870	-1,243 Reduced 10.89%	10,172 $588,000
Q4 2021 Feb 08, 2022	BUY	$40.27 - $56.99 $179,362 - $253,833	4,454 Added 63.99%	11,415 $507,000
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $282,540 - $501,758	-5,957 Reduced 46.11%	6,961 $335,000
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $11,470 - $15,338	157 Added 1.23%	12,918 $1.1 Million
Q1 2021 May 14, 2021	BUY	$70.43 - $97.42 $171,426 - $237,120	2,434 Added 23.57%	12,761 $1.07 Million
Q4 2020 Feb 09, 2021	BUY	$48.9 - $75.26 $209,585 - $322,564	4,286 Added 70.95%	10,327 $777,000
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $13,812 - $18,909	-371 Reduced 5.79%	6,041 $299,000
Q2 2020 Aug 03, 2020	BUY	$28.78 - $46.83 $184,537 - $300,273	6,412 New	6,412 $246,000
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $134,645 - $369,918	-5,274 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$54.18 - $65.64 $63,065 - $76,404	1,164 Added 28.32%	5,274 $287,000
Q3 2019 Nov 12, 2019	BUY	$58.58 - $83.91 $29,114 - $41,703	497 Added 13.76%	4,110 $257,000
Q2 2019 Aug 13, 2019	SELL	$63.59 - $78.71 $5,850 - $7,241	-92 Reduced 2.48%	3,613 $272,000
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $5,328 - $8,456	105 Added 2.92%	3,705 $290,000
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $22,854 - $29,753	-438 Reduced 10.85%	3,600 $202,000
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $153,968 - $276,078	4,038 New	4,038 $262,000

Others Institutions Holding GKOS

# of Institutions

354

Shares Held

47.9M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.93B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Glaukos Corp Transaction History